Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). (2022)
Attributed to:
Respiratory infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/17407745211049829
PubMed Identifier: 34632800
Publication URI: http://europepmc.org/abstract/MED/34632800
Type: Journal Article/Review
Volume: 19
Parent Publication: Clinical trials (London, England)
Issue: 1
ISSN: 1740-7745